2024 annual financial data
Arrowhead Pharmaceuticals 2024 Operating margin
Arrowhead Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -16,927.06%.
Operating income was -601,080,000 USD and net income was -599,493,000 USD.
Operating cash flow was -462,851,000 USD.
Get free Arrowhead Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,551,000 USD
- Operating income
- -601,080,000 USD
- Net income
- -599,493,000 USD
- Operating cash flow
- -462,851,000 USD